BST2 and non-small cell lung carcinoma: For example, in 2015, a non-small cell lung cancer (NSCLC)-related study, which included blood sample data from 109 patients with stage IIIa-IV NSCLC and 110 controls, found that in the advanced NSCLC patients, CD317 and EGFR were highly expressed on the surface of exosomes [25].